Ha. Jaaskelasaari et al., CYTOTOXICITY OF BLEOMYCIN AND EXTERNAL RADIATION IN SQUAMOUS-CELL CANCER CELL-LINES OF HEAD AND NECK, Cancer detection and prevention, 20(4), 1996, pp. 279-284
Bleomycin, a natural antibiotic toxic to dividing cells, has been succ
essfully used in combinations for treatment of recurrent head and neck
cancer. In this study, we investigated five recently established head
and neck squamous cell cancer lines (UT-SCC-2, UT-SCC-8, UT-SCC-9, UT
-SCC-12A, UT-SCC-19A) in terms of response to bleomycin and radiation
treatment. Experiments were carried out using the 96-well plate clonog
enic assay for concentration determinations causing 20% (IC20), 50% (I
C50), and 90% (IC90) inhibition of clonogenic survival and dose-respon
se calculations for bleomycin. Survival fraction after a radiation dos
e of 2 Gy (SF2) was used as a measure for radiation sensitivity. The s
ensitivity for bleomycin was in good accordance with radiation sensiti
vity except for cell line UT-SCC-9. This was the cell line most sensit
ive to radiation (SF2 = 0.25 +/- 0.03) but was fairly resistant to che
motherapy (IC50 = 11.5M). Sensitivity patterns may suggest partly diff
erent mechanisms of action.